DOVER, DE--(Marketwired - Apr 20, 2017) - Metatron (
One of the key updates to note, was the addition of a rate charge for dispensaries using Cannaboids' services. Rates will start at $200 per month, and climb as high as $1000, depending on how extensive their listing is. Metatron wanted to ensure a healthy and sustainable revenue generation was created for their subsidiary Cannaboids. This same market strategy is how WeedMaps was able to generate $400,000 monthly.
The company has received several inquiries about the purchase of their reverse spilt proof Series B shares. As a convenience, a link to the Series B CEO letter is provided below.
In recent news, the US neighboring country Canada has announced legislation to legalize Marijuana. Possession of small amounts of marijuana will be legal throughout the country on July 1, 2018, if the legislation passes. To note, 63 million Americans now live in states where it's legal to even grow cannabis. With Canada announcing its plan to legalize marijuana by 2018, the projected market value of cannabis will only continue to increase. The Cannabis market is on the uptrend of liquidity as more states and countries begun to acquire this resource. Metatron is eager to secure success for their company and its shareholders, and the Cannabis market is that avenue.
As of Mar 21, 2017, the company had 75,371,558 issued and 8,846,557 restricted shares.
The Company has experience in developing over 2000+ mobile applications for top tier clients in the past years with over $3.6 million in sales and millions in downloads.
People interested, can view and download our current live apps focused on health and wellness, cannabis, and message encryption by visiting the app stores below. We plan to update these apps in our upcoming relaunch, and will be adding a more to our list.
Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize...d325075390 Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc Facebook: http://www.facebook.com/metatroninc Twitter: http://twitter.com/metatroninc News: http://metatroninc.com/blog
Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's need for additional financing, which is not assured and which may result in dilution of shareholders, the company's status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward looking statement. Metatron retained Global Discovery Group Inc. for $30,500 for consulting services, CSC Partners for $1,500, Bas1 for $2501 and the company retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.
Contact: Joe Riehl 302-861-0431 ir@metatroninc.com
